作为结核病临床工具的抗体
Sophie McIntyre1,2, Jeffrey Warner1,2, Catherine Rush1,2
1Biomedical Sciences and Molecular Biology, College of Public Health, Medical and Veterinary Sciences, James Cook University, Douglas, QLD, Australia.
Frontiers in immunology
|January 1, 2024
概括
抗体对于了解结核病 (TB) 免疫力至关重要,有助于开发新的诊断,疫苗和治疗方法. 对抗体作用的进一步研究对于全球结核病控制工作至关重要.
科学领域:
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
- 医学研究 医学研究
背景情况:
- 结核病 (TB) 仍然是一个重大的全球卫生挑战,导致严重的发病率和死亡率.
- 目前的结核病控制策略受到保护性免疫力,特别是抗体作用的不完全理解的限制.
- 现有的诊断和治疗方法在资源有限的环境中可能效果较差.
研究的目的:
- 审查基于抗体的结核病临床工具的当前发展情况.
- 突出幽默免疫在结核病诊断,治疗和疫苗设计中的潜力.
- 强调需要更好地了解结核病原和防护中的抗体功能.
主要方法:
- 对结核病血清学,基于抗体的诊断,治疗方法和疫苗的现有文献的审查.
- 对结核病小鼠模型关于抗体介导保护的研究结果的分析.
- 讨论目前人类结核病免疫反应的动物模型的局限性.
主要成果:
- 结核病血清学显示出诊断结核病感染和区分疾病状态的前景,尽管目前没有任何测试符合世卫组织的标准.
- 多重检测可能会提高结核病血清诊断的敏感性和特异性.
- 单克隆抗体疗法和被动抗体输注已在动物模型中显示出保护作用,但人类临床实用性需要进一步验证.
- 有证据表明,一些结核病疫苗可能会诱导对*Mycobacterium tuberculosis* (Mtb) 的保护性抗体.
结论:
- 抗体介导免疫在结核病控制中发挥着重要的,但被低估的作用.
- 进一步研究抗体的功能方面对于推进结核病诊断,治疗和疫苗至关重要.
- 需要开发更好的动物模型,以将基于抗体的干预措施从临床前研究转化为临床应用.
关键词:
抗体是对抗体的重要组成部分.幽默免疫力 幽默免疫力免疫疗法 免疫疗法一个单克隆抗体.菌根细菌 (mycobacteria) 是一种细菌.血清诊断 血清诊断 是一种结核病是一种肺结核病.疫苗,疫苗的使用情况.更多相关视频
09:54Synthesis, Characterization, and Application of Superparamagnetic Iron Oxide Nanoprobes for Extrapulmonary Tuberculosis Detection
Published on: February 16, 2020
5.8K
06:26Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
2.3K
相关概念视频
01:26Pulmonary Tuberculosis IV
143
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
143
01:28Pulmonary Tuberculosis V
180
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
180
01:31Pulmonary Tuberculosis III
332
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
332
01:28Pulmonary Tuberculosis II
240
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
240